AU2009302537A1 - Ovarian cancer biomarkers and uses thereof - Google Patents

Ovarian cancer biomarkers and uses thereof Download PDF

Info

Publication number
AU2009302537A1
AU2009302537A1 AU2009302537A AU2009302537A AU2009302537A1 AU 2009302537 A1 AU2009302537 A1 AU 2009302537A1 AU 2009302537 A AU2009302537 A AU 2009302537A AU 2009302537 A AU2009302537 A AU 2009302537A AU 2009302537 A1 AU2009302537 A1 AU 2009302537A1
Authority
AU
Australia
Prior art keywords
biomarker
ovarian cancer
individual
biomarkers
slpi
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2009302537A
Other languages
English (en)
Inventor
Edward N. Brody
Larry Gold
Rachel M. Ostroff
Marty Stanton
Alex A. E. Stewart
Dominic Zichi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Somalogic Inc
Original Assignee
Somalogic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Somalogic Inc filed Critical Somalogic Inc
Publication of AU2009302537A1 publication Critical patent/AU2009302537A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57449—Specifically defined cancers of ovaries
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Data Mining & Analysis (AREA)
  • Medical Informatics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Evolutionary Biology (AREA)
  • Software Systems (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Evolutionary Computation (AREA)
  • Theoretical Computer Science (AREA)
  • Artificial Intelligence (AREA)
  • Bioethics (AREA)
  • Biophysics (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Databases & Information Systems (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2009302537A 2008-10-06 2009-10-06 Ovarian cancer biomarkers and uses thereof Abandoned AU2009302537A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10314908P 2008-10-06 2008-10-06
US61/103,149 2008-10-06
PCT/US2009/059706 WO2010042525A1 (en) 2008-10-06 2009-10-06 Ovarian cancer biomarkers and uses thereof

Publications (1)

Publication Number Publication Date
AU2009302537A1 true AU2009302537A1 (en) 2010-04-15

Family

ID=42076103

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2009302537A Abandoned AU2009302537A1 (en) 2008-10-06 2009-10-06 Ovarian cancer biomarkers and uses thereof

Country Status (4)

Country Link
EP (1) EP2350917A4 (de)
AU (1) AU2009302537A1 (de)
CA (1) CA2737004A1 (de)
WO (1) WO2010042525A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120040861A1 (en) 2010-08-13 2012-02-16 Somalogic, Inc. Pancreatic Cancer Biomarkers and Uses Thereof
US9322051B2 (en) 2013-10-07 2016-04-26 General Electric Company Probing of biological samples
EP3180611A4 (de) 2014-08-12 2018-04-25 NextGen Jane, Inc. System und verfahren zur überwachung der gesundheit auf basis von gesammelter körperflüssigkeit
EP3442706A4 (de) 2016-04-13 2020-02-19 NextGen Jane, Inc. Probensammel- und konservierungsvorrichtungen, systeme und verfahren
WO2019210052A1 (en) * 2018-04-27 2019-10-31 Laboratory Corporation Of America Holdings Methods and systems for determining the risk of developing ovarian cancer
CN110244733B (zh) * 2019-06-20 2020-06-30 西南交通大学 一种基于改进蚁群算法的移动机器人路径规划方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1573044A4 (de) * 2002-12-18 2006-07-05 Ciphergen Biosystems Inc Serum-biomarker bei lungenkrebs
JP2007502983A (ja) * 2003-08-15 2007-02-15 ユニバーシティ オブ ピッツバーグ オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション がん検出のための多因子アッセイ
ES2610806T3 (es) * 2005-12-22 2017-05-03 Abbott Molecular Inc. Métodos y combinaciones de marcadores para la detección de la predisposición al cáncer de pulmón
WO2007090076A2 (en) * 2006-01-27 2007-08-09 Tripath Imaging, Inc. Methods for identifying patients with an increased likelihood of having ovarian cancer and compositions therefor

Also Published As

Publication number Publication date
WO2010042525A1 (en) 2010-04-15
EP2350917A1 (de) 2011-08-03
EP2350917A4 (de) 2012-06-06
CA2737004A1 (en) 2010-04-15
WO2010042525A9 (en) 2010-11-18

Similar Documents

Publication Publication Date Title
AU2016269430B2 (en) Pancreatic cancer biomarkers and uses thereof
US20100221752A2 (en) Ovarian Cancer Biomarkers and Uses Thereof
AU2015249113B2 (en) Lung cancer biomarkers and uses thereof
US10359425B2 (en) Lung cancer biomarkers and uses thereof
AU2011274422B2 (en) Lung cancer biomarkers and uses thereof
EP3029153B1 (de) Biomarker für mesotheliome und verwendungen davon
CA2847188C (en) Non-small cell lung cancer biomarkers and uses thereof
US20120143805A1 (en) Cancer Biomarkers and Uses Thereof
US20120165217A1 (en) Cancer Biomarkers and Uses Thereof
US20150160225A1 (en) Renal Cell Carcinoma Biomarkers and Uses Thereof
AU2009302537A1 (en) Ovarian cancer biomarkers and uses thereof
US20220065872A1 (en) Lung Cancer Biomarkers and Uses Thereof

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application